CD8A and osteosarcoma: Given the up-regulation of STING expression induced by the SGLT2 inhibitor, we also found that the combined treatment with SGLT2 inhibitor and 2’3’-cGAMP further promoted the infiltration of CD4+ and CD8+ T cells, exerting synergistic antitumor effects in osteosarcoma.